NIH Funding · FY2024
Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#5,907
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.9M across 3 grants · National rank #5907.
Top grants by award amount
Vijayakanth Pagadala's NIH grant portfolio, ranked by award amount.
- $1.1Maward amount
- 2R44HL139187-04R44Development of dekaparin to replace animal-sourced heparin$747.3Kaward amount
- 3R41CA285005-01S1R41National I-Corps: Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation$55Kaward amount
Affiliation
Institutions that have administered grants for Vijayakanth Pagadala.
Affiliated with Glycan Therapeutics Corporation (NC).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardGlycan Therapeutics Corporation
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5907
Related investigators
Other NIH-funded PIs frequently associated with Vijayakanth Pagadala.
Explore further
Find collaborators for Vijayakanth Pagadala
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Glycan Therapeutics Corporation
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →